Average Co-Inventor Count = 8.54
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (31 from 125 patents)
2. Bayer Pharmaceuticals Corporation (6 from 70 patents)
3. Valo Early Discovery, Inc. (5 from 15 patents)
4. Forma Tm2, Inc. (4 from 4 patents)
5. Cara Therapeutics, Inc. (3 from 31 patents)
6. Valo Health, Inc. (3 from 29 patents)
7. Bayer Healthcare LLC (2 from 780 patents)
8. Bayer Intellectual Property Gmbh (2 from 721 patents)
9. Other (1 from 832,761 patents)
10. Smithkline Beecham Corporation (1 from 2,198 patents)
11. Bayer Corporation (1 from 1,008 patents)
12. Bayer Schering Pharma Ag (192 patents)
59 patents:
1. 12275715 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
2. 12018030 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
3. 11795171 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
4. 11739071 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
5. 11498913 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
6. 10981915 - Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
7. 10934299 - Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
8. 10927130 - Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
9. 10906916 - Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
10. 10889567 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
11. 10836741 - Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
12. 10807976 - Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
13. 10577329 - Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
14. 10550098 - Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
15. 10550099 - Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors